Literature DB >> 566509

Endothelial cells in the glaucomato-cyclitic crisis.

K Setälä, A Vannas.   

Abstract

In 21 patients with unilateral glaucomatocyclitic crisis (Posner-Schlossman syndrome) the central corneal endothelium was photographed with a clinical specular microscope. In each patient the endothelial cell density was determined in both the affected and the contralateral healthy eye. In patients who had had several attacks of P-S the endothelial cell density was lower in the affected eye than in the healthy eye (16 cases). 4 patients seen after the first attack and 1 of 3 patients after the second attack had the same cell density in both eyes. Thus, loss of endothelial cells seems to be due mainly to the recurrent attacks of elevated pressure. The role of the inflammatory changes occurring in eyes with the P-S syndrome, especially keratic precipitates, is discussed.

Entities:  

Mesh:

Year:  1978        PMID: 566509

Source DB:  PubMed          Journal:  Adv Ophthalmol        ISSN: 0065-3004


  4 in total

1.  Concurrence of iridocorneal endothelial syndrome in a patient with glaucomatocyclitic crisis.

Authors:  Jin A Choi; Yi Ryeung Park; Tae Yoon La
Journal:  Int J Ophthalmol       Date:  2014-04-18       Impact factor: 1.779

2.  Endothelial cell loss in herpes zoster keratouveitis.

Authors:  A Reijo; V Antti; M Jukka
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

3.  Characteristics of cases needing advanced treatment for intractable Posner-Schlossman syndrome.

Authors:  Kazuichi Maruyama; Yuko Maruyama; Sunao Sugita; Kazuhiko Mori; Yu Yokoyama; Shiho Sanuki-Kunimatsu; Hiroko Nakagawa; Shigeru Kinoshita; Manabu Mochizuki; Toru Nakazawa
Journal:  BMC Ophthalmol       Date:  2017-04-11       Impact factor: 2.209

4.  The characteristics of Posner-Schlossman syndrome: A comparison in the surgical outcome between cytomegalovirus-positive and cytomegalovirus-negative patients.

Authors:  Kazuhiro Murata; Kyoko Ishida; Kenji Ozawa; Akira Sawada; Kiyofumi Mochizuki; Tetsuya Yamamoto
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.